Blood-based fibrosis scores align with liver stiffness measured by two-dimensional shear-wave elastography in type 2 diabetes

Abstract Adults with type 2 diabetes mellitus (T2DM) are at high risk of metabolic dysfunction-associated steatotic liver disease (MASLD). This exploratory cross-sectional analysis examined associations of 18 liver scores, bioimpedance-derived body composition, and three exploratory circulating biomarkers with two-dimensional shear-wave elastography (2D-SWE), shear-wave dispersion (SWD), and attenuation imaging (ATI) in 40 adults with T2DM and suspected liver involvement. Spearman and age- and sex-adjusted partial Spearman correlations were evaluated with false discovery rate (FDR) correction and 10,000-resample bootstrap confidence intervals. Fourteen fibrosis-oriented scores correlated with 2D-SWE after outcome-specific FDR correction; thirteen remained significant across 54 score-ultrasound comparisons. The largest positive coefficient was observed for DiabetesLiver (ρ = 0.527; 95% CI 0.257–0.726), followed by the Fibrosis-4 Index (FIB-4; ρ = 0.516; 95% CI 0.224–0.730). Enhanced Liver Fibrosis (ELF) and LiverRisk correlations were 0.444 (0.153–0.674) and 0.408 (0.076–0.669); broader q ≤ 0.030. ATI correlated with three metabolically weighted scores. No body-composition association survived the broader 75-test correction. No score-SWD or biomarker-ultrasound association met q < 0.05; limited power warrants caution. Moderate associations with liver stiffness do not establish diagnostic equivalence. Findings are consistent with guideline-recommended two-step risk stratification for advanced liver fibrosis in MASLD: FIB-4 followed, when indicated, by liver stiffness measurement or ELF.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-13
DOI
https://doi.org/10.1038/s41598-026-79225-3
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Blood-based fibrosis scores align with liver stiffness measured by two-dimensional shear-wave elastography in type 2 diabetes

Polák Jan, Michal Koc, Iva Hoffmanová, Ulbricht Adam et al.
4 links
Scientific Reports
Liver Disease Diagnosis and Treatment
article

Blood-based fibrosis scores align with liver stiffness measured by two-dimensional shear-wave elastography in type 2 diabetes

Polák Jan, Michal Koc, Iva Hoffmanová, Ulbricht Adam, Čecháková Marie, Schulte Karolin, Elkalaf Moustafa
article en

Abstract

Abstract Adults with type 2 diabetes mellitus (T2DM) are at high risk of metabolic dysfunction-associated steatotic liver disease (MASLD). This exploratory cross-sectional analysis examined associations of 18 liver scores, bioimpedance-derived body composition, and three exploratory circulating biomarkers with two-dimensional shear-wave elastography (2D-SWE), shear-wave dispersion (SWD), and attenuation imaging (ATI) in 40 adults with T2DM and suspected liver involvement. Spearman and age- and sex-adjusted partial Spearman correlations were evaluated with false discovery rate (FDR) correction and 10,000-resample bootstrap confidence intervals. Fourteen fibrosis-oriented scores correlated with 2D-SWE after outcome-specific FDR correction; thirteen remained significant across 54 score-ultrasound comparisons. The largest positive coefficient was observed for DiabetesLiver (ρ = 0.527; 95% CI 0.257–0.726), followed by the Fibrosis-4 Index (FIB-4; ρ = 0.516; 95% CI 0.224–0.730). Enhanced Liver Fibrosis (ELF) and LiverRisk correlations were 0.444 (0.153–0.674) and 0.408 (0.076–0.669); broader q ≤ 0.030. ATI correlated with three metabolically weighted scores. No body-composition association survived the broader 75-test correction. No score-SWD or biomarker-ultrasound association met q < 0.05; limited power warrants caution. Moderate associations with liver stiffness do not establish diagnostic equivalence. Findings are consistent with guideline-recommended two-step risk stratification for advanced liver fibrosis in MASLD: FIB-4 followed, when indicated, by liver stiffness measurement or ELF.

Scientific Reports
Charles University (CZ), Thomayer University Hospital (CZ), University Hospital Kralovske Vinohrady (CZ), Fakultní nemocnice Motol a Homolka (CZ)
European Commission, NextGenerationEU
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon